Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo
Clinical trial NCT06321341 · RECRUITING
Trial details
- NCT number
- NCT06321341
- Sponsor
- Valenta Pharm JSC
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2026-12-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.